Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Caiyun Mu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Anzhi Wang

    China School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, 230012, PR China

    1 shared publication
  • Huiwen Wang

    China School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, 230012, PR China

    1 shared publication
  • Jiaxing Hu

    College of Acumox and Tuina (College of Rehabilitation Medicine), Anhui University of Chinese Medicine, Hefei 230012, China

    1 shared publication
  • Jiayi Yang

    China School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, 230012, PR China

    1 shared publication
  • Jieying Zhang

    China School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, 230012, PR China

    1 shared publication
  • Junnan Jiang

    College of Acumox and Tuina (College of Rehabilitation Medicine), Anhui University of Chinese Medicine, Hefei 230012, China

    1 shared publication

Latest Publications

  • Open Access

    Epimedium: A Versatile Player in Bone Tissue Engineering

    by Tianyou Xu, Rao Zhang, Jiaxing Hu, Junnan Jiang, Longjie Qiao, Sijie Deng, Xinyang Li, Wenjun Zhang, Zhengxin Zhou, Kui Xu, et al.

    Epimedium is a traditional herb that has been investigated for its potential osteogenic and bone-regenerative effects, yet systematic analyses of its multi-component, multi-target mechanisms in bone metabolism and tissue engineering applications are limited. To address this knowledge gap, this narrative review systematically summarizes more than 20 bioactive constituents extracted from various parts of major medicinal Epimedium species. We elaborate on their pivotal roles in modulating osteogenic differentiation, suppressing osteoclastogenesis and bone resorption, regulating inflammatory responses, exerting antioxidant effects, promoting angiogenesis, demonstrating antitumor activity, exerting chondroprotective effects, and exhibiting antibacterial activity during bone defect repair. Furthermore, we highlight recent advancements and current trends in applying these bioactive constituents within the field of bone tissue engineering. Additionally, we compared the osteogenic and osteoprotective potentials of three metabolically related flavonoids (icariin, icaritin, and icariside II). Network pharmacology was utilized to elucidate their multi-target mechanisms in modulating bone metabolism, providing insights for future mechanistic studies. Despite the long-standing clinical use and extensive scientific investigation of Epimedium, this review identifies several challenges associated with its application in bone tissue engineering and offers constructive recommendations to overcome these limitations.

  • A nanoengineered coating with dual antioxidant and immunomodulatory functions on titanium implants for osteoregeneration in osteoporosis

    by Zijian Wang, Rui Yu, Ying Zhou, Jieying Zhang, Jiayi Yang, Huiwen Wang, Anzhi Wang, Wei Jin, Xinkun Shen, Caiyun Mu, et al.